- Home
- PRLD vs NB Comparison
PRLD vs NB Comparison
Compare PRLD & NB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRLD
- NB
- Stock Information
- Founded
- PRLD 2016
- NB 1987
- Country
- PRLD United States
- NB United States
- Employees
- PRLD N/A
- NB N/A
- Industry
- PRLD Medicinal Chemicals and Botanical Products
- NB Metal Mining
- Sector
- PRLD Health Care
- NB Basic Materials
- Exchange
- PRLD Nasdaq
- NB Nasdaq
- Market Cap
- PRLD 63.3M
- NB 56.9M
- IPO Year
- PRLD 2020
- NB N/A
- Fundamental
- Price
- PRLD $1.04
- NB $1.43
- Analyst Decision
- PRLD Buy
- NB Strong Buy
- Analyst Count
- PRLD 3
- NB 1
- Target Price
- PRLD $5.33
- NB $8.50
- AVG Volume (30 Days)
- PRLD 408.0K
- NB 246.9K
- Earning Date
- PRLD 11-06-2024
- NB 11-13-2024
- Dividend Yield
- PRLD N/A
- NB N/A
- EPS Growth
- PRLD N/A
- NB N/A
- EPS
- PRLD N/A
- NB N/A
- Revenue
- PRLD $3,000,000.00
- NB N/A
- Revenue This Year
- PRLD N/A
- NB N/A
- Revenue Next Year
- PRLD N/A
- NB N/A
- P/E Ratio
- PRLD N/A
- NB N/A
- Revenue Growth
- PRLD N/A
- NB N/A
- 52 Week Low
- PRLD $1.00
- NB $1.27
- 52 Week High
- PRLD $6.80
- NB $4.00
- Technical
- Relative Strength Index (RSI)
- PRLD 21.69
- NB 36.87
- Support Level
- PRLD $1.14
- NB $1.33
- Resistance Level
- PRLD $1.36
- NB $1.98
- Average True Range (ATR)
- PRLD 0.11
- NB 0.12
- MACD
- PRLD 0.03
- NB -0.02
- Stochastic Oscillator
- PRLD 7.53
- NB 23.88
About PRLD Prelude Therapeutics Incorporated
Prelude Therapeutics Incorp is a clinical-stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.
About NB NioCorp Developments Ltd.
NioCorp Developments Ltd is engaged in exploration and development of mineral deposits in North America, specifically, the Elk Creek Niobium/Scandium/Titanium property.